Trilipix (choline fenofibrate) is a small molecule pharmaceutical. Choline fenofibrate was first approved as Trilipix on 2008-12-15. Trilipix's patent is valid until 2025-01-07 (FDA).
Trade Name |
Trilipix |
Common Name |
Choline fenofibrate |
Indication |
|
Drug Class |
Antihyperlipidemics (clofibrate type) |